Skip to main content

Inspection visit

Inspection

AYDEN HEALTHCARE OF TOLEDOCMS #3658491 citation on this visit
1 citation recorded

Inspector’s narrative

What the inspector wrote

This survey cited 1 deficiency. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on medical record review and staff interview, the facility failed to ensure residents received ordered medications upon admission. This affected two residents (#15 and #71) of three residents reviewed for admission medications. The facility census was 70. Findings include: 1. Review of the medical record for Resident #71 revealed an admission date of 12/28/23 and discharge date of 01/19/24 with diagnoses including but not limited to metabolic encephalopathy, altered mental status, acute respiratory failure with hypoxia, fluid overload, congestive heart failure, type two diabetes, unspecified convulsions, chronic kidney disease stage three, and cognitive communication deficit. Review of the Minimum Data Set (MDS) assessment dated [DATE] revealed a Brief Interview of Mental Status (BIMS) score of five which indicated Resident #71 had severely impaired cognition. Resident #71 required extensive assistance for Activities of Daily Living (ADLs). Review of physician orders dated 12/28/23 revealed divalproex (Depakote - used to treat seizures) 500 milligrams (mg) twice daily, gabapentin (pain medication) 300 mg three times daily, carvedilol (used heart failure) 25 mg twice daily, and voltaren gel (pain gel) one percent three times daily. Review of the December Medication Administration Record (MAR) revealed resident did not receive Depakote 500 mg in the evening, gabapentin 300 mg at 2:00 P.M. and 9:00 P.M., carvedilol 25 mg at 4:00 P.M. and voltaren gel to knee at 5:00 P.M. on 12/28/23 upon admission. Further review of the medical record revealed no documentation that the medication missed was on hold. Interview on 01/24/24 at 2:40 P.M. with the Director of Nursing (DON) and Licensed Practical Nurse (LPN) #622 verified Resident #71 did not receive medications upon admission due to medications not being available from the pharmacy. LPN #622 stated the Nurse Practitioner (NP) was in the facility that day and stated it was okay to hold the medication until received by the pharmacy. It was further verified there was no documentation available regarding the NP approving medications to be held. 2. Review of medical record for Resident #15 revealed an admission date of 11/27/23 with diagnoses including but not limited to metabolic encephalopathy, altered mental status, Alzheimer's disease, dementia, epilepsy, and hypertension. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 365849 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 365849 B. Wing A. Building (X3) DATE SURVEY COMPLETED 01/24/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Ayden Healthcare of Toledo 4293 Monroe St Toledo, OH 43606 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Review of the MDS assessment dated [DATE] revealed the resident had severely impaired cognition. Resident #15 was dependent for ADLs. Review of physician orders dated 11/27/23 revealed orders for latanoprost ophthalmic solution (eye drops) 0.005 percent (%), lacosamide (used for seizures) 10 mg/milliliters (ml): 10 ml every 12 hours, levetiracetam oral solution (antiepileptic) 100 mg/ml: 15 ml at bedtime. Review of the MAR for November revealed the resident did not receive latanoprost ophthalmic solution, lacosamide 10 ml, and levetiracetam 15 ml at bedtime on 11/27/23. Interview on 01/24/24 at 2:40 P.M. with the Director of Nursing (DON) verified that Resident #15 did not receive medications due to waiting on the pharmacy to deliver. Review of policy titled, Administering Medications, revised December 2012 revealed medications must be administered in accordance with the orders, including any required time frame. This deficiency represents non-compliance investigated under Complaint Number OH00149677. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 365849 If continuation sheet Page 2 of 2

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

1 citation recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0755GeneralS&S Dpotential for harm

    F755 - Pharmacy Services

    Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist.

FAQ · About this visit

Common questions about this visit

What happened during the January 24, 2024 survey of AYDEN HEALTHCARE OF TOLEDO?

This was a inspection survey of AYDEN HEALTHCARE OF TOLEDO on January 24, 2024. The surveyor cited 1 deficiency, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at AYDEN HEALTHCARE OF TOLEDO on January 24, 2024?

Yes, 1 deficiency was cited, each with a CMS Scope and Severity grade. The first was: "Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharm..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

SourceView on CMS Care Compare

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.